OIVD Becomes OIR: FDA Diagnostic Office Adds Entire Radiological Health Program
This article was originally published in The Gray Sheet
Executive Summary
The agency has fully incorporated all of its post-market radiological health regulatory programs into its newly-named Office of In Vitro Diagnostics and Radiological Health.